Full length HIV-1 Gag determines protease inhibitor susceptibility within in vitro assays

Lignende værker

• Gag Determinants of Fitness and Drug Susceptibility in Protease Inhibitor-Resistant Human Immunodeficiency Virus Type 1
  af: Parry, Chris M., et al.
  Udgivet: (2009)
• Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial
  af: Sutherland, Katherine A., et al.
  Udgivet: (2015)
• Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial
  af: Sutherland, Katherine A., et al.
  Udgivet: (2016)
• Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.
  af: Katherine A Sutherland, et al.
  Udgivet: (2015-01-01)
• Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa
  af: Sutherland, Katherine A., et al.
  Udgivet: (2015)